Back

Risks of therapeutic interchange in HFrEF

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure – Treatment Pharmacotherapy HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor Giuseppe Rosano

St Georges Medical School, London (United Kingdom of Great Britain & Northern Ireland)

61 More presentations in this session

Presentation thumbnail
Doctor C. Kapelios (Athens, GR)
Abstract Slides
Presentation thumbnail
Presentation thumbnail
Presentation thumbnail
Mrs C. Ariano (Naples, IT)
Abstract
Presentation thumbnail
Professor P. Rossignol (Monaco, MC)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Session
Is left ventricular ejection fraction still relevant for guideline-directed medical therapy implementation?
18 May 2025
thumbnail
Congress Presentation
Sex-related differences in contemporary HFrEF management: insights from the Italian OpTIMa-HF Registry
29 August 2026
thumbnail
Congress Presentation
Is it safe to initiate four medications in four weeks for HFrEF patients in a normal practice. The experience of a heart failure centre.
29 June 2021
thumbnail
Congress Presentation
Prognostic impact of pharmacotherapy optimisation status in HFrEF patients using a contemporary measurement score
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources